The health care reform laws under the Patient Protection and Affordable Care Act will soon require all Medicare and Medicaid participating DMEPOS suppliers to implement mandatory compliance programs. The presentation will educate owners and operators of such practices on best practices to prepare for this requirement and help ensure compliance with existing Medicare and Medicaid overpayment rules. The presentation will highlight the following:
- How DMEPOS suppliers can create and maintain an effective corporate compliance program.
- How DMEPOS suppliers can comply deal with the “60 Day Refund Rule” requiring self-disclosure of identified overpayments.
- Discuss and comprehend hot topics and key compliance risk areas in the DMEPOS industry.
MedTrade is the largest tradeshow in the world focused exclusively on the HME/DME industry and is designed to provide attendees with high quality and effective, sales, marketing, educational, advocacy and networking opportunities.
Click here to learn more and register for the conference.
People
Related Insights
July 22, 2025
Health Care Law Today
GLP-1 Receptor Agonists: Clinical Trial Considerations
The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
July 21, 2025
Energy Current
DOE Announces Pilot Program to Build Advanced U.S. Nuclear Fuel Supply Lines: What You Need to Know Now
Introduction Coming on the heels of its June 2025 announcement establishing a pilot program for reactor construction and operation in…
July 21, 2025
Labor & Employment Law Perspectives
Considering a Reduction in Force? Some Preliminary Considerations
Employers sometimes find it necessary to make the difficult decision to undergo a reduction-in-force (RIF), resulting in employee layoffs…